Table 2.
Research/clinical gaps |
Contemporary data on the prevalence of PAD in the United States and globally |
Larger studies with toe-brachial index (diagnostic accuracy and prognosis) |
New and noninvasive techniques to visualize peripheral perfusion |
Nonconventional risk factors and microvascular disease as potential preventive and therapeutic targets of PAD |
Research to identify characteristics of effective home-based exercise interventions that are acceptable and accessible to patients with PAD |
Behavioral methods to help patients with PAD adhere to home-based exercise long term |
Community-based studies with severe leg outcomes |
Randomized clinical trials comparing medical therapy, percutaneous revascularization, and surgical revascularization (with their latest evolutions) by indication and clinical staging |
Medications or other oral therapies that significantly improve walking performance in PAD |
Prediction models for developing critical limb ischemia and requiring lower extremity amputation |
All PAD-related studies should include racially/ethnically diverse populations |
Implementation gaps |
Awareness of PAD among health care providers and patients |
Screening of PAD with ankle-brachial index in high-risk populations |
Broader use of toe-brachial index beyond ankle-brachial index>1.4, especially among patients with diabetes or chronic kidney disease |
Adherence to evidence-based therapies in patients with PAD (medical therapies, supervised exercise therapy, and home-based exercise) |
Avoiding unnecessary revascularization |
All these implementation gaps should be filled across racially/ethnically diverse populations |
PAD indicates peripheral artery disease.